Published online before print September 19, 2005, doi: 10.1161/CIRCULATIONAHA.105.548156
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:1965-1970.)
© 2005 American Heart Association, Inc.
Heart Failure |
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
From Charite, Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik II, Abteilung für Kardiologie und Pneumologie, Berlin, Germany.
Reprints requests to Uwe Kühl, PhD, MD, Charite, Universitätsmedizin Berlin, Campus Benjamin-Franklin, Medizinische Klinik II, Abteilung für Kardiologie und Pneumologie, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail uwe.kuehl{at}charite.de
Received March 9, 2005; revision received June 10, 2005; accepted June 24, 2005.
Background— Cardiotropic viral infections have been suspected as one possible cause of myocarditis and dilated cardiomyopathy. Although adverse outcomes in dilated cardiomyopathy patients have been documented, the natural course of heart diseases caused by cardiotropic viruses is unknown.
Methods and Results— Consecutive patients (n=172) with biopsy-proven viral infection in endomyocardial biopsies (EMBs) were followed up by reanalysis of EMBs and hemodynamic measurements after a median period of 6.8 months (range, 5.4 to 11.9). Nested polymerase chain reaction (PCR) and reverse transcription–PCR were performed to analyze the genomic sequences. Myocardial inflammation was assessed by histology and immunohistology. At baseline, 32.6% of EMBs in the study group contained enteroviral (EV) RNA, 8.1% adenovirus (ADV) DNA, 36.6% parvovirus B19 (PVB19) DNA, and 10.5% human herpesvirus type 6 (HHV6) DNA. In 12.2% of the samples, dual infection with PVB19 and HHV6 was present. Follow-up analysis of EMBs by PCR documented spontaneous clearance of viral genomes in 36.2% (55/151) of all patients with single infections. Virus-specific clearance rates were 50% for EV, 35.7% for ADV, 22.2% for PVB19, and 44.4% for HHV6. In patients with dual infection with PVB19+ and HHV6+-, HHV6 was cleared in 42.8% (9/21), whereas PVB19 persisted in all 21 patients. Clearance of viral genomes was associated with a significant improvement in left ventricular ejection fraction (LVEF), improving from 50.2±19.1% to 58.1±15.9% (P<0.001). In contrast, LV function decreased in patients with persisting viral genomes (LVEF, 54.3±16.1% versus 51.4±16.1%, P<0.01).
Conclusions— In this first biopsy-based analysis of the course of viral heart disease, we show that EV, ADV, PVB19, and HHV6 persistence detected in the myocardium of patients with LV dysfunction was associated with a progressive impairment of LVEF, whereas spontaneous viral elimination was associated with a significant improvement in LV function.
Key Words: heart diseases • myocarditis • cardiomyopathy • polymerase chain reaction • immunohistochemistry
This article has been cited by other articles:
 |
|
 |
|
  H. Baccouche, H. Mahrholdt, G. Meinhardt, R. Merher, M. Voehringer, S. Hill, K. Klingel, R. Kandolf, U. Sechtem, and A. Yilmaz Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease Eur. Heart J., December 1, 2009; 30(23): 2869 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bobbert, A. Weithauser, J. Andres, T. Bobbert, U. Kuhl, H. P. Schultheiss, U. Rauch, and C. Skurk Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy Eur J Heart Fail, December 1, 2009; 11(12): 1163 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Schultz, A. A. Hilliard, L. T. Cooper Jr, and C. S. Rihal Diagnosis and Treatment of Viral Myocarditis Mayo Clin. Proc., November 1, 2009; 84(11): 1001 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Frustaci, M. A. Russo, and C. Chimenti Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study Eur. Heart J., August 2, 2009; 30(16): 1995 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hombach, N. Merkle, J. Torzewski, J. M. Kraus, M. Kunze, O. Zimmermann, H. A. Kestler, and J. Wohrle Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy Eur. Heart J., August 2, 2009; 30(16): 2011 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L.P. Caforio, F. Tona, A. Vinci, A. Ramondo, L. Cacciavillani, L. Leoni, S. Iliceto, F. Calabrese, G. Thiene, A. Angelini, et al. Myocarditis mimicking Takotsubo cardiomyopathy or Takotsubo cardiomyopathy with secondary inflammation?: reply Eur J Heart Fail, August 1, 2009; 11(8): 810 - 810. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jakel, U. Kuckelkorn, G. Szalay, M. Plotz, K. Textoris-Taube, E. Opitz, K. Klingel, S. Stevanovic, R. Kandolf, K. Kotsch, et al. Differential Interferon Responses Enhance Viral Epitope Generation by Myocardial Immunoproteasomes in Murine Enterovirus Myocarditis Am. J. Pathol., August 1, 2009; 175(2): 510 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noutsias, S. Pankuweit, B. Maisch, D. Huzly, M. Enders, and S. Pollak Pathophysiological Mechanisms of Parvovirus B19 Infection J. Clin. Microbiol., July 1, 2009; 47(7): 2358 - 2359. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Klempa, D. H. Kruger, B. Auste, M. Stanko, A. Krawczyk, K. F. Nickel, K. Uberla, and A. Stang A Novel Cardiotropic Murine Adenovirus Representing a Distinct Species of Mastadenoviruses J. Virol., June 1, 2009; 83(11): 5749 - 5759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yajima and K. U. Knowlton Viral Myocarditis: From the Perspective of the Virus Circulation, May 19, 2009; 119(19): 2615 - 2624. [Full Text] [PDF]
|
|
|
|
 |
|
 R. RAMARAJ and V. L. SORRELL Peripartum cardiomyopathy: Causes, diagnosis, and treatment Cleveland Clinic Journal of Medicine, May 1, 2009; 76(5): 289 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Cooper Jr. Myocarditis N. Engl. J. Med., April 9, 2009; 360(15): 1526 - 1538. [Full Text] [PDF]
|
|
|
|
 |
|
 M. FREMONT, K. METZGER, H. RADY, J. HULSTAERT, and K. DE MEIRLEIR Detection of Herpesviruses and Parvovirus B19 in Gastric and Intestinal Mucosa of Chronic Fatigue Syndrome Patients In Vivo, March 1, 2009; 23(2): 209 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mahrholdt and U. Sechtem Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: are we there yet? J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 139 - 142. [Full Text] [PDF]
|
|
|
|
|
|
S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schenk, M. Enders, S. Pollak, R. Hahn, and D. Huzly High Prevalence of Human Parvovirus B19 DNA in Myocardial Autopsy Samples from Subjects without Myocarditis or Dilative Cardiomyopathy J. Clin. Microbiol., January 1, 2009; 47(1): 106 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Comar, P D'Agaro, C Campello, A Poli, J P Breinholt III, J A Towbin, and M Vatta Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease J. Clin. Pathol., January 1, 2009; 62(1): 80 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Holzmann, A. Nicko, U. Kuhl, M. Noutsias, W. Poller, W. Hoffmann, A. Morguet, B. Witzenbichler, C. Tschope, H.-P. Schultheiss, et al. Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period Circulation, October 21, 2008; 118(17): 1722 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dennert, H. J. Crijns, and S. Heymans Acute viral myocarditis Eur. Heart J., September 1, 2008; 29(17): 2073 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S D Treadwell, B Thanvi, and T G Robinson Stroke in pregnancy and the puerperium Postgrad. Med. J., May 1, 2008; 84(991): 238 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gutberlet, B. Spors, T. Thoma, H. Bertram, T. Denecke, R. Felix, M. Noutsias, H.-P. Schultheiss, and U. Kuhl Suspected Chronic Myocarditis at Cardiac MR: Diagnostic Accuracy and Association with Immunohistologically Detected Inflammation and Viral Persistence Radiology, February 1, 2008; 246(2): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J K S Chia and A Y Chia Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach J. Clin. Pathol., January 1, 2008; 61(1): 43 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zurney, K. E. Howard, and B. Sherry Basal Expression Levels of IFNAR and Jak-STAT Components Are Determinants of Cell-Type-Specific Differences in Cardiac Antiviral Responses J. Virol., December 15, 2007; 81(24): 13668 - 13680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Sechtem, H Mahrholdt, and H Vogelsberg Cardiac magnetic resonance in myocardial disease Heart, December 1, 2007; 93(12): 1520 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Waldman and J. B. Kopp Parvovirus B19 and the Kidney Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S47 - S56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur. Heart J., June 1, 2007; 28(11): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Heymans Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools Eur. Heart J., June 1, 2007; 28(11): 1279 - 1280. [Full Text] [PDF]
|
|
|
|
|
|
L. G. Spagnoli, S. Pucci, E. Bonanno, A. Cassone, F. Sesti, A. Ciervo, and A. Mauriello Persistent Chlamydia pneumoniae Infection of Cardiomyocytes Is Correlated with Fatal Myocardial Infarction Am. J. Pathol., January 1, 2007; 170(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lupescu, C.-T. Bock, P. A. Lang, S. Aberle, H. Kaiser, R. Kandolf, and F. Lang Phospholipase A2 Activity-Dependent Stimulation of Ca2+ Entry by Human Parvovirus B19 Capsid Protein VP1 J. Virol., November 15, 2006; 80(22): 11370 - 11380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mahrholdt, A. Wagner, C. C. Deluigi, E. Kispert, S. Hager, G. Meinhardt, H. Vogelsberg, P. Fritz, J. Dippon, C. -T. Bock, et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis Circulation, October 10, 2006; 114(15): 1581 - 1590. [Abstract] [Full Text] [PDF]
|
|